A similar percentage (26.1%) of PTK2 gene amplification was reported also by the whole-genome sequencing (WGS) demonstrating that this is one of the most prevalent and potentially actionable mutations in HCC [15]. The gene discussed is PTK2; the disease is hepatocellular carcinoma.